Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission 2025-10-09 20:50
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™ 2025-10-09 19:00
Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87 2025-10-09 17:27
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology 2025-10-09 13:10
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 2025-10-09 11:41
Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution 2025-10-09 09:58
Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul 2025-10-09 04:41
TCI Biotech Releases 2024 ESG Report, Showcasing Brand Transformation, Global Sustainability Commitments, and Award-Winning Impact 2025-10-08 23:00
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025 2025-10-08 22:20
India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research 2025-10-08 21:48
Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System 2025-10-08 21:00
Covation Biomaterials Highlights Milestones for CovationBio® bioPTMEG at K-Show 2025 2025-10-08 16:06
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology 2025-10-08 08:15
Cyteph Completes Recruitment for Phase I Clinical Trial of CYT-101 in Patients with Recurrent Glioblastoma Multiforme Brain Cancer 2025-10-08 06:00
Celaid Therapeutics Raises JPY 1.055 Billion (USD 7.2 Million) in the First Close of its Series B Financing 2025-10-07 21:00
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program 2025-10-07 20:30
Terumo Blood and Cell Technologies Honored with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2025 Regional Edition 2025-10-07 13:25
Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets 2025-10-06 20:15
FDA Lifts Clinical Hold on NUZ-001 2025-10-06 14:06
Taiwan Pavilion Fostering Collaborative Innovation in AI, Regenerative Medicine and CDMO at BioJapan 2025 2025-10-06 07:15
1 14 15 16 17 18 525